News and Announcements

The Latest

Dr. Elias and Dr. Diamond in pre-op appointment

Sounding Out the Future of Focused Ultrasound

The University of Virginia’s Dr. Jeffrey Elias was among the first in the world to use focused ultrasound technology to treat patients with essential tremor, a condition akin to Parkinson’s disease that affects up to 10 million Americans.
UVA Today
og_newsroomuvahealthcom_2020_05_06_focused-ultrasound-opening-brain-to-impossible-treatments_.jpg

Focused Ultrasound Opening Brain to Impossible Treatments

Focused ultrasound, the researchers hope, could revolutionize treatment for conditions from Alzheimer’s to brain tumors and even stroke.
UVA Health Newsroom
og_newsvirginiaedu_content_qa-researcher-jarrett-zigon-says-theres-better-response-opioid-crisisutm_sourceDailyReport_u.jpg

Q&A: Researcher Jarrett Zigon Says There’s a Better Response to the Opioid Crisis

The bioethicist and anthropologist believes community-building tactics – like those used in Canada and Europe – can help opioid users in the U.S.
UVA Today
og_givinguvahealthcom_article_stilling-parkinsons-tremors.jpg

Stilling Parkinson's Tremors

Private support from benefactors has helped speed clinical trials, including Jeffrey Elias’s focused ultrasound trials for essential tremors.
UVA Health Giving
og_newsvirginiaedu_content_uvas-brain-institute-focuses-alzheimers-autism-addiction-and-injury.jpg

UVA’s Brain Institute Focuses on Alzheimer’s, Autism, Addiction and Injury

An institute founded as part of the University’s Cornerstone Plan brings together faculty from a range of disciplines to tackle complex problems involving the brain.
UVA Today
og_newsvirginiaedu_content_researcher-seeks-unravel-brains-genetic-tapestry-tackle-rare-disorder.jpg

Researcher Seeks to Unravel the Brain’s Genetic Tapestry to Tackle Rare Disorder

The Bow Foundation has helped support Mike McConnell’s genetic epilepsy research.
UVA Today
Person holding pill bottle

New Hope for Patients with Parkinson’s Disease

John Mitchell’s clinical research endowment in his wife’s name supported Jeffrey Elias and Binit Shah’s highly selective drug therapies for Parkinson’s disease research.
PULSE